GPD1L Activators
The chemical class known as GPD1L Activators comprises a group of compounds with the potential to influence the activity of the GPD1L protein by targeting specific cellular pathways involved in metabolism. These activators include AICAR, metformin, rosiglitazone, fenofibrate, forskolin, pioglitazone, oleic acid, and palmitic acid, each of which operates through distinct pathways.
AICAR and metformin act as activators of the AMP-Activated Protein Kinase (AMPK) pathway, enhancing cellular energy regulation. Activation of AMPK can lead to downstream effects on glucose and lipid metabolism, influencing GPD1L - it interacts with this pathway. Rosiglitazone and fenofibrate serve as activators of Peroxisome Proliferator-Activated Receptors (PPARs), affecting lipid metabolism. GPD1L, associated with lipid metabolism, can be indirectly modulated by PPAR activators through changes in lipid metabolism-related gene expression. Forskolin elevates intracellular cAMP levels and activates Protein Kinase A (PKA), leading to phosphorylation events impacting various cellular processes. If GPD1L is connected to this pathway, forskolin may indirectly affect its activity. Pioglitazone, similar to rosiglitazone, activates PPAR-gamma, influencing genes related to glucose and lipid metabolism, potentially affecting GPD1L. Oleic acid and palmitic acid, fatty acids with distinct saturated or monounsaturated properties, can modulate lipid metabolism pathways. Changes in lipid levels, including increased oleic or palmitic acid, may indirectly influence GPD1L if it plays a role in lipid metabolism. These GPD1L activators collectively act through diverse signaling pathways that can impact cellular metabolism and related processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR activates the AMP-Activated Protein Kinase (AMPK) pathway, potentially influencing GPD1L if it is linked to AMPK signaling. | ||||||
1,1-Dimethylbiguanide, Hydrochloride | 1115-70-4 | sc-202000F sc-202000A sc-202000B sc-202000C sc-202000D sc-202000E sc-202000 | 10 mg 5 g 10 g 50 g 100 g 250 g 1 g | $20.00 $43.00 $63.00 $156.00 $260.00 $510.00 $31.00 | 37 | |
Metformin is an activator of the AMPK pathway, leading to downstream effects on glucose and lipid metabolism, which may indirectly impact GPD1L. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
Rosiglitazone activates Peroxisome Proliferator-Activated Receptor (PPAR)-gamma, potentially influencing GPD1L by affecting lipid metabolism. | ||||||
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $41.00 | 9 | |
Fenofibrate is another activator of PPARs, specifically PPAR-alpha, impacting lipid metabolism and potentially modulating GPD1L. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin elevates cAMP levels and activates Protein Kinase A (PKA), leading to phosphorylation events that may indirectly modulate GPD1L. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
Pioglitazone activates PPAR-gamma, influencing genes related to glucose and lipid metabolism, which can potentially affect GPD1L. | ||||||
Oleic Acid | 112-80-1 | sc-200797C sc-200797 sc-200797A sc-200797B | 1 g 10 g 100 g 250 g | $37.00 $104.00 $580.00 $1196.00 | 10 | |
Oleic acid, a monounsaturated fatty acid, can affect lipid metabolism pathways, potentially influencing GPD1L if it is connected to these processes. | ||||||
Palmitic Acid | 57-10-3 | sc-203175 sc-203175A | 25 g 100 g | $114.00 $286.00 | 2 | |
Palmitic acid, a saturated fatty acid, can impact lipid metabolism pathways, potentially influencing GPD1L if it is associated with lipid metabolism. | ||||||